Yasser Mohamed Atef

Dr. Yasser Mohamed Atef

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

16 October 2019 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
YAYasser Mohamed Atef
Yasser Mohamed Atef
OEOmnia Safwat El-Deeb
Omnia Safwat El-Deeb
MSMona Tayssir Sadek
Mona Tayssir Sadek
RGRehab Abo El gheit
Rehab Abo El gheit
MEMarwa Nagy Emam
Marwa Nagy Emam
RERasha Osama El-Esawy
Rasha Osama El-Esawy

9 August 2023 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
OEOmnia Safwat El-Deeb
Omnia Safwat El-Deeb
YHYasser Mostafa Hafez
Yasser Mostafa Hafez
AEAmira Kamel Eltokhy
Amira Kamel Eltokhy
MAMarwa Mahmoud Awad
Marwa Mahmoud Awad
RERehab Ahmed Ahmed El-Shaer
Rehab Ahmed Ahmed El-Shaer
YAYasser Mohamed Atef
Yasser Mohamed Atef

2 March 2022 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
YAYasser Mohamed Atef
Yasser Mohamed Atef
MEMarwa Nagy Emam
Marwa Nagy Emam
RGRehab E. Abo El Gheit
Rehab E. Abo El Gheit
EEEman M. Elbeltagi
Eman M. Elbeltagi
HAH. A. Alshenawy
H. A. Alshenawy
RARania Nagi Abd-Ellatif
Rania Nagi Abd-Ellatif
Geraniol (GE), an important ingredient in several essential oils, displayed pleiotropic biological activities through targeting multiple signaling cascades. In the current study, we aimed to examine the protective effect of GE on d-galactose (d-gal) induced cognitive impairment and explore the underlying mechanisms. Forty male Wistar rats (8 weeks old) were randomly categorized into 4 groups; Group I (saline + vehicle [edible oil]), group II (saline + geraniol) (100 mg/kg/day orally), group III (d-galactose) (100 mg/kg/day subcutaneously injected), and group IV (d-galactose + geraniol). Behavioral impairments were evaluated. Brain levels of malondialdehyde (MDA) and reduced glutathione (GSH) as well as superoxide dismutase (SOD) and acetylcholinesterase (AchE) activities were estimated. The levels of inflammatory markers [tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, IL-6, and nuclear factor kappa beta (NF-kβ)], endoplasmic reticulum stress sensors [inositol requiring protein 1(IRE1) and protein kinase RNA–like endoplasmic reticulum kinase (PERK)], brain-derived neurotrophic factor (BDNF), and mitogen-activated protein kinases (MAPK) pathway were measured by ELISA. Also, hippocampal histopathological assessment and immunohistochemical analysis of glial fibrillary acidic protein (GFAP) and caspase-3 were performed. Glucose regulated protein 78 (GRP78) and C/EBP homologous protein (CHOP) mRNA expression and protein levels were assessed. GE effectively ameliorated aging-related memory impairment through increasing GSH, BDNF, Ach levels, and SOD activity. Additionally, GE treatment caused a decrease in the levels of MDA, inflammatory mediators, and ER stress sensors as well as the AchE activity together with concomitant down-regulation of GRP78 and CHOP mRNA expression. Moreover, GE improved neuronal architecture and rat's spatial memory; this is evidenced by the shortened escape latency and increased platform crossing number. Therefore, GE offers a unique pharmacological approach for aging-associated neurodegenerative disorders. Graphical Abstract

1 November 2018 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
YHYasser Mostafa Hafez
Yasser Mostafa Hafez
OEOmnia Safwat El-Deeb
Omnia Safwat El-Deeb
YAYasser Mohamed Atef
Yasser Mohamed Atef

12 April 2023 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
YAYasser Mohamed Atef
Yasser Mohamed Atef
YHYasser Mostafa Hafez
Yasser Mostafa Hafez
OEOmnia Safwat El‐Deeb
Omnia Safwat El‐Deeb
EBEman H. Basha
Eman H. Basha
RIRadwa Ismail
Radwa Ismail
ATamira el tokhy
amira el tokhy